TOPIC
Sublicense
3 stories covering sublicense — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
NurExone Announces Sublicense Agreement for U.S. Subsidiary
NurExone Biologic Inc. grants sublicense rights to Exo-Top Inc. to support U.S. manufacturing and development of exosome therapies.
NurExone Biologic Inc. Announces Sublicense Agreement for U.S. Manufacturing
NurExone Biologic Inc. grants sublicense rights to its U.S. subsidiary Exo-Top Inc. to support manufacturing and development of exosome therapies, as announced on March 26, 2026.
Hopewell Therapeutics Sublicenses LNPs to Foxcroft for Cancer Vaccine Development
Hopewell Therapeutics grants a global sublicense of its tissue-targeting LNPs to Foxcroft Therapeutics for novel cancer vaccines, including financial terms and planned collaborations.
Daily capital raising signals
Get fund close, LP allocation, and deal flow news before it hits the mainstream.
